Sign in
4

Changes in Ownership

Cytosorbents Corp Filed Acc 0001104659-23-126431

Chief Medical Officer bought 22,557 shares at $1.33 ($30,001)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Deliargyris Efthymios Chief Medical Officer 2023-12-13 Purchase +22,557 $1.33 $30,001 348,433 D
Derivatives
Deliargyris Efthymios Chief Medical Officer 2023-12-13 Purchase · Common Stock Warrant (Right to Buy) +7,894 7,894 D
Open-market purchases · 22,557 sh · avg $1.33 · $30,001
Loading xslF345X05/tm2332958-4_4seq1.xml…